跳到正文
原文
Endpoints News 生物医药· Anna Brown·· 8 天前AI 评分27

Merck KGaA 因 Lonza 协议减值 3.66 亿欧元

Merck KGaA's writedown over Lonza deal; PharmaLogic buys Lantheus' CDMO business

AI 导读

Merck KGaA 因向 Lonza 销售合同计提 3.66 亿欧元减值损失。PharmaLogic 购买了 Lantheus 的 CDMO 业务。

正文

Mer­ck KGaA’s im­pair­ment hit from CD­MO sale: The Ger­man con­glom­er­ate re­port­ed a €366 mil­lion ($405.8 mil­lion) im­pair­ment loss on its busi­ness sale to Lon­za, ac­cord­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news